Mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy

European Journal of Endocrinology

Volumn 172, Issue 1, 2015, Pages R23-R30

  Riester, Anna ^a   Reincke, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPLERENONE; MINERALOCORTICOID ANTAGONIST; SPIRONOLACTONE;

ADRENALECTOMY; BREAST FEEDING; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; HUMAN; HYPERTENSION; HYPOKALEMIA; LAPAROSCOPIC SURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA RENIN ACTIVITY; PREGNANCY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TREATMENT PLANNING; ANALOGS AND DERIVATIVES; ANIMAL; DISEASE MANAGEMENT; FEMALE; HYPERALDOSTERONISM; PREGNANCY COMPLICATIONS;

ANIMALS; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERALDOSTERONISM; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PREGNANCY; PREGNANCY COMPLICATIONS; SPIRONOLACTONE;

EID: 84920485151     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0444     Document Type: Review

References (61)

1. Verdonk K, Visser W, Van Den Meiracker AH & Danser AH. The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and bad. Clinical Science 2014 126 537-544. (doi:10.1042/CS20130455)
2. Derkx FH, Alberda AT, de Jong FH, Zeilmaker FH, Makovitz JW & Schalekamp MA. Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failure. Journal of Clinical Endocrinology and Metabolism 1987 65 349-354. (doi:10.1210/jcem-65-2-349)
3. Irani RA & Xia Y. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 2008 29 763-771. (doi:10.1016/j.placenta.2008.06.011)
4. Ledoux F, Genest J, Nowaczynski W., Kuchel O & Lebel M. Plasma progesterone and aldosterone in pregnancy. Canadian Medical Association Journal 1975 112 943-947.
5. Gant NF, Daley GL, Chand S, Whalley PJ & MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. Journal of Clinical Investigation 1973 52 2682-2689. (doi:10.1172/JCI107462)
6. Anton L & Brosnihan KB. Systemic and uteroplacental renin-angiotensin system in normal and pre-eclamptic pregnancies. Therapeutic Advances in Cardiovascular Disease 2008 2 349-362. (doi:10.1177/1753944708094529)
7. Merrill DC, Karoly M, Chen K., Ferrario CM & Brosnihan KB. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002 18 239-245. (doi:10.1385/ENDO:18:3:239)
8. AbdAlla S, Lother H, el Massiery A & Quitterer U. Increased AT(1) receptor heterodimersinpreeclampsia mediate enhanced angiotensin II responsiveness. Nature Medicine 2001 7 1003-1009. (doi:10.1038/nm0901-1003)
9. Quitterer U, Lother H & Abdalla S. AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia. Seminars in Nephrology 2004 24 115-119. (doi:10.1016/j.semnephrol.2003.11.007)
10. Herse F & LaMarca B. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. American Journal of Reproductive Immunology 2013 69 413-418. (doi:10.1111/aji.12072)
11. Wallukat G, Homuth V, Fischer T., Lindschau C, Horstkamp B, Jupner A., Baur E, Nissen E, Vetter K., Neichel D et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. Journal of Clinical Investigation 1999 103 945-952. (doi:10.1172/JCI4106)
12. Zhou CC, Zhang Y, Irani R.A., Zhang H., Mi T, Popek EJ, Hicks M.J., Ramin SM, Kellems RE & Xia Y. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nature Medicine 2008 14 855-862. (doi:10.1038/nm.1856)
13. Granger JP, LaMarca BB, Cockrell K, Sedeek M., Balzi C, Chandler D & Bennett W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods in Molecular Medicine 2006 122 383-392.
14. LaMarca B, Wallukat G, Llinas M., Herse F, Dechend R & Granger JP. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor a in pregnant rats. Hypertension 2008 52 1168-1172. (doi:10.1161/HYPERTENSIONAHA. 108.120576)
15. Rossitto G, Regolisti G, Rossi E., Negro A, Nicoli D, Casali B., Toniato A, Caroccia B, Seccia T.M., Walther T et al. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma. Hypertension 2013 61 526-533. (doi:10.1161/HYPERTENSIONAHA.112.202945)
16. Kem DC, Li H, Velarde-Miranda C, Liles C., Vanderlinde-Wood M, Galloway A, Khan M., Zillner C, Benbrook A, Rao V et al. Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism. Journal of Clinical Endocrinology and Metabolism 2014 99 1790-1797. (doi:10.1210/jc.2013-3282)
17. Hopkins MP. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. American Journal of Obstetrics and Gynaecology 2000 183 1-258. (doi:10.1067/mob.2000.107928)
18. Wyckoff JA, Seely EW, Hurwitz S, Anderson B.F., Lifton RP & Dluhy RG. Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension 2000 35 668-672. (doi:10.1161/01.HYp.35.2.668)
19. Zezza L, Ralli E, Conti E., Passerini J, Autore C & Caserta D. Hypertension in pregnancy: the most recent findings in pathophysiology, diagnosis and therapy. Minerva Ginecologica 2014 66 103-126.
20. Okawa T, Asano K, Hashimoto T., Fujimori K, Yanagida K & Sato A. Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature. American Journal of Perinatology 2002 19 031-036. (doi:10.1055/s-2002-20170)
21. Cabassi A, Rocco R, Berretta R., Regolisti G & Bacchi-Modena A. Eplerenone use in primary aldosteronism during pregnancy. Hypertension 2012 59 e18-e19. (doi:10.1161/HYPERTENSIONAHA. 111.187237)
22. Kosaka K, Onoda N, Ishikawa T., Iwanaga N, Yamamasu S, Tahara H., Inaba M, Ishimura E, Ogawa Y & Hirakawa K. Laparoscopic adrena-lectomy on a patient with primary aldosteronism during pregnancy. Endocrine Journal 2006 53 461-466. (doi:10.1507/endocrj.K05-122)
23. Shalhav A, Landman J, Afane J., Levi R & Clayman RV. Laparoscopic adrenalectomy for primary hyperaldosteronism during pregnancy. Journal of Laparoendoscopic & Advanced Surgical Techniques 2000 10 169-171. (doi:10.1089/lap.2000.10.169)
24. Shigematsu K, Nishida N, Sakai H., Igawa T, Suzuki S, Kawai K & Takahara O. Primary aldosteronism with aldosterone-producing adenoma consisting of pure zona glomerulosa-type cells in a pregnant woman. Endocrine Pathology 2009 20 66-72. (doi:10.1007/s12022-009-9060-8)
25. Nezu M, Miura Y, Noshiro T & Inoue M. Primary aldosteronism as a cause of severe postpartum hypertension in two women. American Journal of Obstetrics and Gynaecology 2000 182 745-746. (doi:10.1067/mob.2000.104229)
26. Nursal TZ, Caliskan K, Ertorer E., Parlakgumus A & Moray G. Laparoscopic treatment of primary hyperaldosteronism in a pregnant patient. Canadian Journal of Surgery 2009 52 E188-E190.
27. Albiger N, Sartorato P, Mariniello B., Iacobone M, Finco I, Fassina A & Mantero F. A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion? European Journal of Endocrinology 2011 164 405-412. (doi:10.1530/EJE-10-0879)
28. Robar CA, Poremba JA, Pelton J.J., Hudson L & Higby K. Current diagnosis and management of aldosterone-producing adenomas during pregnancy. Endocrinologist 1998 8 403-408. (doi:10.1097/00019616-199811000-00003)
29. Matsumoto J, Miyake H, Isozaki T., Koshino T & Araki T. Primary aldosteronism in pregnancy. Journal of Nippon Medical School 2000 67 275-279. (doi:10.1272/jnms.67.275)
30. Al-Ali N., El-Sandabesee D, Steel S & Roland J. Conn's syndrome in pregnancy successfully treated with amiloride. Journal of Obstetrics and Gynaecology 2007 27 730-731. (doi:10.1080/01443610701667098)
31. Kreze A Jr, Kothaj P., Dobáková M & Rohon S. Primary aldosteronism caused by aldosterone-producing adenoma in pregnancy - complicated by EPH gestosis. Wiener Klinische Wochenschrift 1999 111 855-857.
32. Germain A, Kottman C & Valdes G. Primary aldosteronism and pregnancy: report of 2 cases. Revista Medica de Chile 2002 130 1399-1405. (doi:10.4067/S0034-98872002001200010)
33. Krysiak R, Samborek M & Stojko R. Primary aldosteronism in pregnancy. Acta Clinica Belgica 2012 67 130-134. (doi:10.1179/ACB.67. 2.2062644)
34. Riester A, Fischer E, Degenhart C., Reiser MF, Bidlingmaier M, Beuschlein F, Reincke M & Quinkler M. Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism. Journal of Clinical Endocrinology and Metabolism 2014 99 E1035-E1039. (doi:10.1210/jc.2013-3789)
35. Rossi GP, Bernini G, Caliumi C., Desideri G, Fabris B, Ferri C., Ganzaroli C, Giacchetti G, Letizia C & Maccario M. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. Journal of the American College of Cardiology 2006 48 2293-2300. (doi:10.1016/j.jacc.2006.07.059)
36. Pallauf A, Schirpenbach C, Zwermann O., Fischer E, Morak M, Holinski-Feder E, Hofbauer L., Beuschlein F & Reincke M. The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience. Hormone and Metabolic Research 2012 44 215-220. (doi:10.1055/s-0031-1299730)
37. Goland RS, Wardlaw SL, Stark R.I., Brown LS Jr & Frantz AG. High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. Journal of Clinical Endocrinology and Metabolism 1986 63 1199-1203. (doi:10.1210/jcem-63-5-1199)
38. Mulatero P, di Cella SM, Williams TA, Milan A, Mengozzi G, Chiandussi L., Gomez-Sanchez CE & Veglio F. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree. Journal of Clinical Endocrinology and Metabolism 2002 87 3187-3191. (doi:10.1210/jcem.87.7.8647)
39. Ronconi V, Turchi F, Zennaro M.C., Boscaro M & Giacchetti G. Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism. Clinical Endocrinology 2011 74 278-279. (doi:10.1111/j.1365-2265.2010.03901.x)
40. Rigo J Jr, Glaz E & Papp Z. Low or high doses of spironolactone for treatment of maternal Bartter's syndrome. American Journal of Obstetrics and Gynaecology 1996 174 297. (doi:10.1016/S0002-9378(96)70418-0)
41. Groves TD & Corenblum B. Spironolactone therapy during human pregnancy. American Journal of Obstetrics and Gynaecology 1995 172 1655-1656. (doi:10.1016/0002-9378(95)90549-9)
42. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstetrics and Gynaecology 2013 122 1122-1131. (doi:10.1097/01.AOG.0000437382.03963.88)
43. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F., Stowasser M, Young WF Jr & Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 3266-3281. (doi:10.1210/jc. 2008-0104)
44. Kamoun M, Mnif MF, Charfi N, Kacem F.H., Naceur BB, Mnif F, Dammak M, Rekik N & Abid M. Adrenal diseases during pregnancy: pathophysiology, diagnosis and management strategies. American Journal of Medical Sciences 2014 347 64-73. (doi:10.1097/MAJ. 0b013e31828aaeee)
45. Rossi GP, Auchus RJ, Brown M, Lenders J.W., Naruse M., Plouin PF, Satoh F & Young WF. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 2014 63 151-160. (doi:10.1161/HYPERTENSIONAHA.113.02097)
46. Funder J. Evolution of how best to manage primary aldosteronism. Foreword. Reviews in Endocrine and Metabolic Disorders 2011 12 1. (doi:10.1007/s11154-011-9173-5)
47. Higgins HP & O'Sullivan M. Use of an aldosterone antagonist in the diagnosis of primary hyperaldosteronism. Canadian Medical Association Journal 1960 83 1289-1292.
48. Morton A, Panitz B & Bush A. Eplerenone for gitelman syndrome in pregnancy. Nephrology 2011 16 349. (doi:10.1111/j.1440-1797.2010. 01396.x)
49. Nocke L, Breuer H, Klink R., Lichton IR & Nocke W. Influence of spironolactone on the excretion of C21-, C19-, and C18 steroids in pregnant and nonpregnant women. Acta Endocrinologica Supplementum 1971 152 41.
50. Lammintausta R & Erkkola R. Effect of spironolactone treatment on the renin-aldosterone system during pregnancy. International Journal of Clinical Pharmacology and Biopharmacy 1979 17 294-298.
51. Rose LI, Regestein Q & Reckler JM. Lack of effect of spironolactone on male genital development. Investigative Urology 1975 13 95-96.
52. Hecker A, Hasan SH & Neumann F. Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinologica 1980 95 540-545.
53. Shah A. Ambiguous genitalia in a newborn with spironolactone exposure, 93rd Annual Meeting of the Endocrine Society: abstr., Vol 4, P3-227, 2011.
54. Nohira T, Nakada T, Akutagawa O., Fujito A, Okabe K, Ioya N & Yoshida M. Pregnancy complicated with Bartter's syndrome: a case report. Journal of Obstetrics and Gynaecology Research 2001 27 267-274. (doi:10.1111/j.1447-0756.2001.tb01268.x)
55. de Arriba G., Sanchez-Heras M & Basterrechea MA. Gitelman syndrome during pregnancy: a therapeutic challenge. Archives of Gynecology and Obstetrics 2009 280 807-809. (doi:10.1007/s00404-009-0994-3)
56. Rušavý Z, Hudec A, Karbanová J, Korečko V, Janů R & Kališ V. Gitelman syndrome in pregnancy - a severe hypokalemia with favorable perinatal prognosis. Ceská gynekologie/Ceská lékarská spolecnost Jan Evangelista Purkyne 2012 77 421-423.
57. Levy J & Marx GF. Problems related to aldosteronism during cesarean section. Anesthesiology 1971 34 294-297. (doi:10.1097/00000542-197103000-00021)
58. Lotgering FK, Derkx FM & Wallenburg H. Primary hyperaldosteronism in pregnancy. American Journal of Obstetrics and Gynaecology 1986 155 986-988. (doi:10.1016/0002-9378(86)90331-5)
59. Crane MG, Andes JP, Harris JJ & Slate WG. Primary aldosteronism in pregnancy. Obstetrics and Gynaecology 1964 23 200-208.
60. Craft J. Eplerenone (Inspra), a new aldosterone antagonist for the treatment of systemic hypertension and heart failure. Proceedings (Baylor University. Medical Center) 2004 17 217-220.
61. Hutter DA, Berkowitz R, Davis SE & Ashtyani H. Application of continuous positive airway pressure in hypoxemic acute respiratory failure associated with diastolic dysfunction in pregnancy. Congestive Heart Failure 2006 12 174-175. (doi:10.1111/j.1527-5299.2005.05316.x)